Skip to main content

Table 2 Differential expressions of PD-1,PD-L1 and PD-L2 between the primary and metastatic tumors

From: Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma

 

Primary(N = 83)

Metastasis (N = 163)a

n(%)

Lung/lymph node n = 72

Bone n = 41

Brain n = 19

Viscera n = 16

Adrenal gland n = 6

Others n = 20

Total n(%)

PD-1

 Negative

57(68.7)

25(34.7)

28(68.3)

17(89.5)

14(87.5)

5(83.3)

12(60.0)

101(58.0)

 Positive

26(31.3)

47(65.3)

13(31.7)

2(10.5)

2(12.5)

1(16.7)

8(40.0)

73(42.0)

 P value

 

< 0.001

0.77

< 0.001

0.01

0.21

0.85

0.11

PD-L1

 Negative

63(75.9)

45(62.5)

36(87.8)

13(68.4)

11(68.8)

5(83.3)

14(70.0)

124(71.3)

 Positive

20(24.1)

27(37.5)

5(12.2)

6(31.6)

5(31.3)

1(16.7)

6(30.0)

50(28.7)

 P value

 

0.03

0.01

0.77

 

0.51

0.89

0.44

PD-L2

 Negative

69(83.1)

55(76.4)

31(75.6)

17(89.5)

10(62.5)

3(50.0)

17(85.0)

133(76.4)

 Positive

14(16.9)

17(23.6)

10(24.4)

2(10.5)

6(37.5)

3(50.0)

3(15.0)

41(23.6)

 P value

 

0.99

0.21

0.16

0.17

0.12

0.34

0.22

  1. a11 cases have two metastatic sites